| scholarly article | Q13442814 |
| P50 | author | Mark J. Crabtree | Q42533046 |
| Keith Channon | Q56420294 | ||
| P2093 | author name string | Ashley B Hale | |
| Nicholas J Alp | |||
| Amy L Tatham | |||
| P2860 | cites work | Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway | Q72611416 |
| Regulation of 6-pyruvoyltetrahydropterin synthase activity and messenger RNA abundance in human vascular endothelial cells | Q77465329 | ||
| Guidelines for the management of rheumatoid arthritis: 2002 update | Q78501880 | ||
| Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3 | Q24323220 | ||
| Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells | Q24323362 | ||
| Tetrahydrobiopterin biosynthesis, regeneration and functions | Q24531994 | ||
| Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes | Q24653313 | ||
| Anticancer Antifolates: Current Status and Future Directions | Q28207632 | ||
| Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo | Q28270463 | ||
| The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study | Q28609860 | ||
| Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer | Q33722120 | ||
| Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase | Q33863119 | ||
| Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence | Q33937018 | ||
| Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice | Q34794990 | ||
| Hypercholesterolemia increases endothelial superoxide anion production | Q35610616 | ||
| Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy | Q36142613 | ||
| Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors | Q36253833 | ||
| Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells | Q37176379 | ||
| Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. | Q37294875 | ||
| Superoxide and peroxynitrite in atherosclerosis | Q37558573 | ||
| Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression | Q39916287 | ||
| Radiochemical HPLC detection of arginine metabolism: measurement of nitric oxide synthesis and arginase activity in vascular tissue | Q40285898 | ||
| Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs | Q41921106 | ||
| Tetrahydrobiopterin biosynthesis. Studies with specifically labeled (2H)NAD(P)H and 2H2O and of the enzymes involved | Q42225151 | ||
| Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin | Q42242064 | ||
| Formation of a protonated trihydrobiopterin radical cation in the first reaction cycle of neuronal and endothelial nitric oxide synthase detected by electron paramagnetic resonance spectroscopy. | Q43568582 | ||
| Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants | Q44177935 | ||
| Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice | Q44714954 | ||
| Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay | Q45015147 | ||
| Tetrahydrobiopterin uptake in supplemental administration: elevation of tissue tetrahydrobiopterin in mice following uptake of the exogenously oxidized product 7,8-dihydrobiopterin and subsequent reduction by an anti-folate-sensitive process | Q45092363 | ||
| Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells | Q45193952 | ||
| IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction | Q46805078 | ||
| Neurochemical effects following peripheral administration of tetrahydropterin derivatives to the hph-1 mouse. | Q49087031 | ||
| Formation of a Pterin Radical in the Reaction of the Heme Domain of Inducible Nitric Oxide Synthase with Oxygen† | Q57837809 | ||
| Determination of quinonoid dihydrobiopterin by high-performance liquid chromatography and electrochemical detection | Q69385952 | ||
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| endothelium | Q111140 | ||
| Nitric oxide synthase 3 | Q408853 | ||
| sapropterin | Q419808 | ||
| GTP cyclohydrolase 1 | Q1487359 | ||
| Dihydrofolate reductase | Q14819390 | ||
| regulation of removal of superoxide radicals | Q14864571 | ||
| P304 | page(s) | 28128-36 | |
| P577 | publication date | 2009-10-09 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways | |
| P478 | volume | 284 |
| Q37723167 | A key role for tetrahydrobiopterin-dependent endothelial NOS regulation in resistance arteries: studies in endothelial cell tetrahydrobiopterin-deficient mice |
| Q37682336 | A novel role for endothelial tetrahydrobiopterin in mitochondrial redox balance |
| Q34541077 | Animal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacology |
| Q36811746 | Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation in Dhfr |
| Q26772926 | B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review |
| Q40374460 | Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure |
| Q35132173 | C-terminus of heat shock protein 70-interacting protein-dependent GTP cyclohydrolase I degradation in lambs with increased pulmonary blood flow |
| Q92824774 | CR6-interacting factor 1 deficiency reduces endothelial nitric oxide synthase activity by inhibiting biosynthesis of tetrahydrobiopterin |
| Q38842311 | Caffeine ameliorates hyperoxia-induced lung injury by protecting GCH1 function in neonatal rat pups |
| Q38991320 | Cell type-specific recycling of tetrahydrobiopterin by dihydrofolate reductase explains differential effects of 7,8-dihydrobiopterin on endothelial nitric oxide synthase uncoupling |
| Q47350829 | Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion |
| Q38048842 | Coronary heart disease in type 2 diabetes: mechanisms and comprehensive prevention strategies |
| Q43220700 | Dexamethasone, tetrahydrobiopterin and uncoupling of endothelial nitric oxide synthase. |
| Q36223027 | Dihydrofolate reductase 19-bp deletion polymorphism modifies the association of folate status with memory in a cross-sectional multi-ethnic study of adults |
| Q43267895 | Dihydrofolate reductase and biopterin recycling in cardiovascular disease |
| Q35064669 | Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency |
| Q41908167 | Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major |
| Q90535685 | Downregulated GTCPH I/BH4 Pathway and Decreased Function of Circulating Endothelial Progenitor Cells and Their Relationship with Endothelial Dysfunction in Overweight Postmenopausal Women |
| Q36593434 | Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation |
| Q37760426 | Endothelial activation and circulating markers of endothelial activation in kidney disease |
| Q37711251 | Endothelial dysfunction in diabetes: multiple targets for treatment |
| Q41231498 | Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity |
| Q48552624 | Folate: a possible role in erectile dysfunction? |
| Q35022284 | Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm |
| Q39523681 | Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells |
| Q35747905 | GCH1, BH4 and pain |
| Q51767539 | Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides. |
| Q89997560 | HPAanalyze: an R package that facilitates the retrieval and analysis of the Human Protein Atlas data |
| Q34163760 | Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency |
| Q35170674 | Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation |
| Q34875396 | Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury |
| Q35061758 | Impairment of nitrergic system and delayed gastric emptying in low density lipoprotein receptor deficient female mice. |
| Q35190872 | Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. |
| Q37088422 | Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice |
| Q35021915 | Increasing muscle mass improves vascular function in obese (db/db) mice |
| Q42532978 | Integrated redox sensor and effector functions for tetrahydrobiopterin- and glutathionylation-dependent endothelial nitric-oxide synthase uncoupling |
| Q64105077 | Knockout of dihydrofolate reductase in mice induces hypertension and abdominal aortic aneurysm via mitochondrial dysfunction |
| Q38926317 | Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. |
| Q35204865 | Measurement of NO in biological samples |
| Q36753476 | Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension |
| Q88899477 | Mechanisms of Normal Tissue Injury From Irradiation |
| Q89748484 | Methotrexate and its mechanisms of action in inflammatory arthritis |
| Q34727664 | Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes |
| Q37881801 | Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy |
| Q26770958 | Modulation of Radiation Response by the Tetrahydrobiopterin Pathway |
| Q37655580 | Molecular mechanisms underlying the activation of eNOS. |
| Q49501122 | Nitric oxide signalling in cardiovascular health and disease. |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q44590697 | Oral BH4: a novel remedy for age-related skin microvascular impairment during heat stress or fool's elixir? |
| Q90425859 | Oral delivery of xenon for cardiovascular protection |
| Q64864242 | Parkinson's disease in GTP cyclohydrolase 1 mutation carriers |
| Q26859449 | Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease |
| Q37144494 | Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts. |
| Q28235401 | Queuosine deficiency in eukaryotes compromises tyrosine production through increased tetrahydrobiopterin oxidation |
| Q38241490 | Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide |
| Q26822833 | Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling |
| Q36221276 | Reperfusion injury and reactive oxygen species: The evolution of a concept |
| Q42919719 | Reply: To PMID 25882860. |
| Q92948413 | Repurposing of Tranilast for Potential Neuropathic Pain Treatment by Inhibition of Sepiapterin Reductase in the BH4 Pathway |
| Q94464751 | Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases |
| Q42718346 | S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling |
| Q57023975 | SEPIAPTERIN, ALLEVIATES IMPAIRED GASTRIC nNOS FUNCTION IN SPONTANEOUS DIABETIC FEMALE RODENTS THROUGH NRF2 mRNA TURNOVER and miRNA BIOGENESIS PATHWAY |
| Q50294476 | Salvage - BH2 is reduced to BH4 by DHFR |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q97905672 | Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli |
| Q37728038 | Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications |
| Q37873087 | Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease |
| Q34252918 | Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease |
| Q42355197 | Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality |
| Q37860512 | Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin |
| Q90176575 | Tetrahydrobiopterin Plays a Functionally Significant Role in Lipogenesis in the Oleaginous Fungus Mortierella alpina |
| Q40536337 | Tetrahydrobiopterin Supplementation Improves Phenylalanine Metabolism in a Murine Model of Severe Malaria. |
| Q35850060 | Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women |
| Q33687812 | Tetrahydrobiopterin in cardiovascular health and disease |
| Q35001320 | Tetrahydrobiopterin restores diastolic function and attenuates superoxide production in ovariectomized mRen2.Lewis rats |
| Q50238440 | Tetrahydrobiopterin: a vascular redox target to improve endothelial function. |
| Q36117830 | The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease. |
| Q38169252 | The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury |
| Q38103265 | The regulation of vascular tetrahydrobiopterin bioavailability |
| Q34836065 | The role of reactive oxygen species in microvascular remodeling |
| Q42773113 | Trimethoprim-Sulfamethoxazole-Induced Psychosis Culminating in Catastrophic Self-Injury: A Case Report |
| Q41968122 | Uncoupling endothelial nitric oxide synthase is ameliorated by green tea in experimental diabetes by re-establishing tetrahydrobiopterin levels |
| Q50303119 | Unintended consequences of inhibiting dihydrofolate reductase through folic acid supplementation: inattentive-type attention deficit hyperactivity disorder and ASD connections. |
| Q35610656 | Vascular Aging across the Menopause Transition in Healthy Women |
| Q37431006 | eNOS uncoupling and endothelial dysfunction in aged vessels |
| Q39073685 | α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease |
Search more.